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A protein discovered within inner mitochondrial membranes (IMM), designated as the mitochondrial ryanodine receptor (mRyR), has been
recognized recently as a modulator of Ca2+ fluxes in mitochondria. The present study provides fundamental pharmacological and
electrophysiological properties of this mRyR. Rat cardiac IMM fused to lipid bilayers revealed the presence of a mitochondrial channel with
gating characteristics similar to those of classical sarcoplasmic reticulum RyR (SR-RyR), but a variety of other mitochondrial channels obstructed
clean recordings. Mitochondrial vesicles were thus solubilized and subjected to sucrose sedimentation to obtain mRyR-enriched fractions.
Reconstitution of sucrose-purified fractions into lipid bilayers yielded Cs+-conducting, Ca2+-sensitive, large conductance (500–800 pS) channels
with signature properties of SR-RyRs. Cytosolic Ca2+ increased the bursting frequency and mean open time of the channel. Micromolar
concentrations of ryanodine induced the appearance of subconductance states or inhibited channel activity altogether, while Imperatoxin A
(IpTxa), a specific activator of RyRs, reversibly induced the appearance of distinct subconductance states. Remarkably, the cardiac mRyR
displayed a Ca2+ dependence of [3H]ryanodine binding curve similar to skeletal RyR (RyR1), not cardiac RyR (RyR2). Overall, the mRyR
displayed elemental attributes that are present in single channel lipid bilayer recordings of SR-RyRs, although some exquisite differences were
also noted. These results therefore provide the first direct evidence that a unique RyR occurs in mitochondrial membranes.
© 2007 Published by Elsevier B.V.Keywords: Mitochondria; Ryanodine receptor; Planar lipid bilayer; Single channel recording; Imperatoxin A; Calcium1. Introduction
Extracellular Ca2+ influx through the dihydropyridine
receptor induces the opening of Ca2+ release channels in
cardiac muscle, giving rise to the Ca2+-induced-Ca2+ release
(CICR) mechanism that triggers muscle contraction [1,2]. The
Ca2+ release channel that is essential for excitation–contrac-
tion (E–C) coupling is a ∼2 million Da homotetrameric
protein of the sarcoplasmic reticulum (SR) that binds
ryanodine with high specificity and affinity; hence it is
named the ryanodine receptor (RyR) [3–5]. A variety of
endogenous substances have been described to regulate RyR
activity, including Ca2+, Mg2+, ATP, H+, calmodulin, several
protein kinases [6,7], and accessory proteins like sorcin and⁎ Corresponding author. Tel.: +1 608 265 5960; fax: +1 608 265 7821.
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doi:10.1016/j.bbamem.2007.04.011FKBP12 [8]. Likewise, several exogenous regulators of RyR
activity, although not directly associated with the CICR
mechanism, play an important role in defining the pharmaco-
logical profile of the RyR [9]. These modulators include:
ryanodine [10], caffeine [11], dantrolene [12], and scorpion
peptide toxins [13], among others. Overall, the role of the RyR
in E–C coupling, its pharmacological properties, and its
molecular identity are fairly well characterized.
Recently, studies have shown that an inner mitochondrial
membrane (IMM) protein runs with identical mobility to SR-
RyRs in SDS-PAGE, cross-reacts with RyR antibodies, and
mediates ryanodine- and dantrolene-sensitive Ca2+ fluxes
[14,15]. It is possible, therefore, that a mitochondrial channel
protein with signature features of the RyR (i.e. a mitochon-
drial RyR, mRyR) may be an integral component of the Ca2+
transport system of mitochondria. If verified, this would
undoubtedly be a surprising topological location for a RyR
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RyR localization within cardiomyocytes. In this study, we
fused purified mitochondrial membranes into planar lipid
bilayers and determined the existence of a mitochondrial
channel that behaves remarkably similar to SR-RyRs. We
show that the unitary channel conductance and open
probability of this presumed mRyR in the presence of some
of the most classical modulators of RyR activity, including:
Ca2+, ryanodine, and Imperatoxin A (IpTxa, is a 3.7 kDa
peptide toxin, isolated from the venom of the scorpion Pan-
dinus imperator, with high affinity to and exquisite selectivity
for RyRs) are remarkably similar to those of the SR-RyR.
However, a unique identifying feature of this mRyR was its
Ca2+-dependence of activity curve, which was similar to that
of skeletal RyR (RyR1), instead of that of cardiac RyR
(RyR2), as would be expected from its tissue localization.
These results were in concordance with those of Beutner et al.
[14,15] and reinforce the notion that a mRyR is an integral
component of mitochondrial membranes and not a residual
component of SR. Several studies support the idea that
mitochondria sequester significant amounts of mobilized
cytosolic Ca2+ in cardiac muscle cells, thereby shaping cyto-
solic Ca2+ transients [16–21], and also controlling cellular
energy production on a beat-by-beat basis [22]. Thus, a
potential role of the mRyR may be to modulate Ca2+ fluxes in
the mitochondria through Ca2+-induced Ca2+ uptake, perhaps
simultaneously functioning as a transducer for excitation–
metabolism coupling in cardiac cells [15].
2. Materials and methods
2.1. Materials
[3H]ryanodine was purchased from NEN Life Science Products (Shelton,
CT). The antibody against the voltage-dependent anion channel (VDAC) was
obtained from Calbiochem (San Diego, CA) and the antibodies against the
sarco- and endoplasmic reticulum Ca2+-ATPase (SERCA2) and calsequestrin
were from Santa Cruz Biotechnology (Santa Cruz, CA). Porcine brain
phosphatidylethanolamine and phosphatidylserine were purchased from Avanti
Polar Lipids (Birmingham, AL). Precast SDS-polyacrylamide gels were from
Bio-Rad (Hercules, CA). All other chemicals were purchased from Sigma (St.
Louis, MO) unless otherwise noted.
2.2. Methods
2.2.1. Isolation of rat heart mitochondria
Heart mitochondria were isolated in isotonic ice-cold mannitol/sucrose
buffer (M/S buffer; in mM: 225 mannitol, 75 sucrose, 0.5 EGTA, 1 glutathione,
10 HEPES, pH 7.4) by differential centrifugation and subsequent purification on
a Percoll gradient as described previously [23].
2.2.2. Preparation of mitochondrial subfractions
Mitochondrial subfractions were prepared as described previously [14,24].
Isolated mitochondria from rat hearts were osmotically shocked in 10 mM
Na2HPO4/NaH2PO4 for 20 min on ice followed by the addition of sucrose
(20% final concentration). Mitochondrial membranes were disrupted by
sonication (two times for 30 s), and eventually intact mitochondria were
removed by centrifugation at 7000×g. The supernatant was transferred as a
final layer onto a continuous sucrose gradient (from 60% to 30% sucrose in
10 mM HEPES, pH 7.4, plus protease inhibitor cocktail (Roche Molecular
Biochemicals, Indianapolis, IN)) and centrifuged for at least 8 h at 70,000×g
to separate mitochondrial membrane vesicles. The mitochondrial subfractionswere tested for specific marker proteins: succinate dehydrogenase (SDH) for
IMM (detailed below), creatine kinase for contact sites (CS) between IMM
and outer mitochondrial membrane (OMM), and the VDAC for OMM. The
characterized CS and IMM fractions were diluted 2-fold with M/S buffer,
which contained protease inhibitor cocktail, and centrifuged for 90 min at
300,000×g to sediment the mRyR. The pellet was resuspended in a small
volume of M/S buffer and was stored in liquid nitrogen until needed. The
IMM samples used for these experiments tested negative for SERCA2,
calsequestrin, and VDAC (marker proteins for the SR and OMM,
respectively). Likewise, the CS samples tested negative for SERCA, but
were slightly contaminated with VDAC.
2.2.3. Succinate dehydrogenase test
Succinate dehydrogenase (SDH) was measured enzymatically according to
the procedure of Pette [25]. Two to 5 μl sample volume (for IMM) or 50 to
100 μl sample volume (for other mitochondrial subfractions) was added to an
assay mixture containing (in mM): 1 sodium phosphate, 1 potassium cyanide,
0.1 phenazine methosulfate and 0.1 cytochrome c. The reaction was started with
10 mM succinate. The increase of absorbance was measured with a Genesis 5
spectrophotometer at 550 nm.
2.2.4. Denaturing SDS-PAGE and Western blot analysis
For the determination of SERCA and calsequestrin contamination within the
mitochondrial preparations, aliquots (50 μg and 30 μg, respectively) of
mitochondrial subfractions were loaded in 10% SDS-polyacrylamide gels. The
separated proteins were transferred onto nitrocellulose membranes for 90 min at
100 V. Western blots were performed using the Amersham enhanced
chemiluminescence assay. To determine the validity of the RyR purifications
(described below), some of the collected fractions were stained with silver salts
by modifications of a previously described procedure [26]. Briefly, 40 μg of
protein was subjected to SDS-polyacrylamide gel electrophoresis in a 7.5%
polyacrylamide precast mini-gel. The gel was incubated for 1 h in 50 ml of
fixing solution (ethanol: glacial acetic acid: water; 15:5:30). After discarding the
fixing solution, the gel was incubated two times in 50 ml of 30% ethanol for
30 min with gentle shaking. The gel was washed 3 times, 10 min each, in 100 ml
of water and then incubated for 30 min in a silver solution (AgNO3:H2O; 1:20).
After washing with deionized water, the gel was treated with 50 ml of an
aqueous solution containing 2.5% sodium carbonate and 0.02% formaldehyde
until stained bands were apparent. The reaction was quenched by washing the
gel in 1% acetic acid for a few minutes followed by washing with deionized
water.
2.2.5. Preparation of SR-enriched microsomes from skeletal and cardiac
muscle
Skeletal SR was isolated from frog hind leg muscles and cardiac SR was
isolated from rat hearts by differential centrifugation as described [27,28].
Briefly, dissected muscle was placed in ice-cold saline solution (0.9% NaCl,
10 mM Tris–HCl, pH 6.8), minced to small pieces, weighed, and homo-
genized with 3 volumes of saline solution in a Waring blender for 2 min at
high speed. The saline solution contained the following protease inhibitors:
leupeptin (12 μM), phenylmethylsulphonyl fluoride (PMSF; 100 μM),
benzamidine (10 μM), and aprotinin (10 μM). The blended tissue was
homogenized more thoroughly using a Brickmann Polytron (three times for
15 s each on setting 2). The homogenate was centrifuged at 4000×g for
20 min, and the resultant supernatant was filtered through 4 layers of cheese
cloth and centrifuged again at 8000×g for 20 min. The supernatant from the
8000×g spin was centrifuged at 40,000×g for 30 min. The 40,000×g pellet,
containing the SR-microsomes, was resuspended in a sucrose buffer
(containing 0.3 M sucrose, 0.1 M KCl, 5 mM Na-PIPES, pH 6.8), aliquoted,
quickly frozen, and stored at −80 °C before use.
2.2.6. Purification of SR-RyR and mRyR
The frog skeletal microsomes and isolated IMM and CS subfractions were
subsequently purified via sucrose gradient centrifugation [5,29]. The thawed
samples were diluted 1:1 with solubilization buffer (final concentrations: 1 M
NaCl, 40 mM Na-PIPES, 100 μM CaCl2, 0.5% CHAPS, 1:5000 dilution of
protease inhibitor cocktail (Sigma), pH 7.2) and incubated for 1 h on ice. The
solubilized preparations were sedimented by centrifugation at 4 °C for 40 min in
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solubilized samples was layered on top of 32 ml continuous sucrose gradients
(containing 5–20% sucrose, 0.3 M NaCl, 40 mM Na-PIPES, 300 μM CaCl2,
0.1% CHAPS, pH 7.5). Following centrifugation in a Beckman SW28 rotor for
at least 16 h at 76,000×g at 4 °C, fractions were collected (automatic pump set at
1.5 ml/tube) from the bottom of the tube upwards (with fraction #1 containing
20% sucrose and the final fraction containing 5% sucrose). This fractionation
resulted in 20 tubes per gradient, and each fraction was silver-stained (see above)
and tested for [3H]ryanodine binding activity, as performed by Valdivia et al.
[30], in order to localize the RyR in the gradients. The first 4 fractions of each
gradient contained the highest counts of RyR activity. To facilitate fusion of the
mRyR into lipid bilayers, these fractions were aliquoted together and
reconstituted into proteoliposomes using the procedure of Lee et al. [31].
2.2.7. [3H]ryanodine binding assay
[3H]ryanodine binding to mitochondrial membrane vesicles was carried out as
described previously [14]. Briefly, 100 μg of rat heart mitochondrial membranes
were incubated in 0.17 M KCl, 10 mM MOPS (pH 7.0), 10 nM [3H]ryanodine,
and with various concentrations of CaCl2 to set free Ca
2+ concentration in the
range of 100 nM to 1 mM (total volume 500 μl). The incubation occurred in the
presence (+IpTxa) or absence (control) of 1 μM IpTxa and lasted for 4 h at 37 °C.
Likewise, [3H]ryanodine binding to rat cardiac SR was carried out as described
previously [32]. Briefly, the standard incubation medium contained 0.2 M KCl,
30 mM Mops (pH 6.8), 100 μg of cardiac microsomes, 10 nM [3H]ryanodine,
1 mMEGTA, and CaCl2 necessary to set free concentration of Ca
2+ in the range of
10 nM to 10 mM (total volume 100 μl). The incubation occurred in the presence
(+IpTxa) or absence (control) of 1 μM IpTxa and lasted 90 min at 37 °C. Samples
were always run in duplicate, filtered onto glass fiber filters (Whatman GF/C), and
washed three times with 5 ml of cold water using a Brandel M-24R cell harvester
(Gaithersburg, MD). The filters were placed in scintillation vials, 7 ml of liquid
scintillation mixture was added, and the retained radioactivity was measured in a
Beckman LS-6500 β-counter. The specific binding was defined as the difference
between the binding in the absence (total binding) and presence (nonspecific
binding) of 10 μM unlabeled ryanodine.
2.2.8. Planar bilayer recordings of RyRs
Our single channel recordings in lipid bilayers were performed as described
previously for the SR-RyR [32,33]. The mRyRs or purified frog skeletal RyRs
were reconstituted into planar lipid bilayers composed of phosphatidylethano-
lamine and phosphatidlyserine (1:1) dissolved in decane at a concentration of
20 mg/ml. Single channel data were collected at steady negative voltages (which
varied depending on the experiment) in symmetrical 300 mM cesium (Cs+)
methanesulfonate, 20 mM Na–HEPES, pH 7.2. Proteoliposomes or purified
RyRs were added to the cis (cytosolic) side of the chamber, which contained the
voltage command electrode. The trans chamber contained the reference electrode
and corresponded to the luminal side of the channel. In this configuration, Cs+
flows from the luminal to the cytosolic side at negative holding potentials. Cs+
was chosen as the charge carrier to increase the channel conductance and to avoid
interference from K+ channels present in the SR and inner mitochondrial
membranes. Chloride channels were mostly blocked by replacing chloride with
the impermeant methanesulfonate anion. Contaminant Ca2+ (∼3–5 μM, as
determined by a Ca2+ electrode) served to activate RyRs. In some experiments,
50 μMCaCl2, 10 μM ryanodine, or 500 nM IpTxa was added to the cis side of the
channel, as detailed in the text. Some of the recordings were also made with
20 mM KCl added to both sides of the chamber in order to stimulate channel
activity [34], as specified in the text. Channel activity was filtered with an 8-pole
low pass Bessel filter set at 1.5 kHz and digitized at a rate of 4 kHz using a
Digidata 1200 AD/DA interface. Data acquisition and analysis were performed
with Axon Instruments (Burlingame, CA) hardware and software (pClamp 8).3. Results
3.1. The mRyR is distinct from the SR-RyR
Calsequestrin and SERCA are specific marker proteins for
the SR. To determine if the rat heart mitochondrial subfractionshad any SR contamination, Western blots performed with an
antibody against the cardiac isoform of SERCA (SERCA2a)
showed that the rat cardiac SR-containing cytosol (Fig. 1A, lane
1), but not mitochondrial subfractions (Fig. 1A, lanes 2–6) had
immunoreactivity against this antibody. Likewise, cardiac SR
and mitochondrial vesicles from rat hearts retained the presence
of calsequestrin (Fig. 1B, lanes 1–2); however, further
purification and separation of mitochondrial vesicles into
OMM, CS, and IMM completely removed calsequestrin from
these preparations. All IMM fractions were free of the VDAC, a
marker protein for the OMM (not shown, see [14,15]). The CS
fraction, consisting of attachments of the OMM and IMM, was
mostly SERCA2a-free (Fig. 1A, lane 3). To further ensure the
quality of the IMM fraction, we measured the activity of
succinate dehydrogenase, an IMM-resident enzyme. During the
purification of IMM vesicles the activity of this enzyme should
increase because matrix proteins or proteins of the OMM are
removed. As indicated in Table 1, the specific activity for
succinate dehydrogenase increased from 1.35±1.06 mU/mg
protein in the OMM to 2598.6±318.6 mU/mg protein in the
IMM. We used IMM vesicles in most lipid bilayer experiments
after verifying the lack of detection of OMM and SR proteins.
Thus, we can safely ascertain that the channels we labeled
“mRyR” in this study are localized in the mitochondria and do
not correspond to SR channels.
To further demonstrate that the IMM fractions were not
contaminated with SR components, we conducted Ca2+-
dependence of [3H]ryanodine binding curves to IMM and SR
vesicles from rat hearts. The rationale was based on the
surprising finding that the mRyR cross-reacts with an anti-RyR1
(skeletal isoform) antibody, not an anti-RyR2 antibody [15].
Further, if IMM contained RyRs from SR vesicles, then both
preparations would show a RyR2-like response to Ca2+, which
differs from a RyR1-like response in the modest Ca2+-
dependent inactivation occurring at high [Ca2+]. Finally, we
conducted these experiments in the absence and the presence of
IpTxa, a high-affinity peptide ligand of RyRs [32,35] that affects
differently the Ca2+-dependence of [3H]ryanodine binding
curve to RyR1 and RyR2 channels. IpTxa increases [
3H]
ryanodine binding to RyR1 at all [Ca2+], but it produces dual
effect on RyR2, initially increasing (pCa 7–5) and then
decreasing (pCa 4-2) [3H]ryanodine binding. The result is in
an augmented bell-shaped curve in RyR1 and a sigmoidal curve
in RyR2 [32,35]. Thus, IpTxa could exaggerate RyR isoform-
dependent differences in [3H]ryanodine binding, which could
help estimate the level of SR contamination in our mitochon-
drial membranes. Fig. 1C shows the Ca2+ dependence of [3H]
ryanodine binding to the isolated cardiac mitochondrial vesicles
and the effect of IpTxa. Specific binding in the absence of IpTxa
(control) had a threshold for detection at∼100 nM Ca2+ (pCa 7)
and was maximal at 10 μM Ca2+ (pCa 5). Higher Ca2+
concentrations decreased [3H]ryanodine binding, resulting in a
bell-shaped curve remarkably similar to that of RyR1 [32,35]. In
the presence of IpTxa (+IpTxa) the binding curve was also bell-
shaped but significantly augmented by ∼2-fold (see figure
legend). By contrast, the Ca2+-dependence of [3H]ryanodine
binding to SR vesicles displayed a different profile (Fig. 1D,
Fig. 1. Western blot of SERCA and calsequestrin in mitochondrial subfractions and the effect of IpTxa on the Ca
2+ dependence of [3H]ryanodine binding.
Mitochondrial subfractions from isolated and osmotically shocked rat heart mitochondria were probed with SERCA2a (A) and calsequestrin (B) antibodies to test for
contamination of the IMM and CS with SR or cytosolic membrane fragments (50 μg and 30 μg of protein per lane in each blot, respectively). The arrows indicate the
positions and approximate molecular weights of the SERCA2a and calsequestrin proteins, respectively. Each numbered lane corresponds to the cellular preparation
listed to the right of each immunoblot. Rat cardiac SR vesicles were used as positive controls for each blot (lane 1). The binding of [3H]ryanodine to rat mitochondrial
vesicles (C) and rat cardiac SR (D) was performed as described in Materials and methods. IpTxa (1 μM) was either present (+IpTxa, dashed line) or absent (control,
solid line) throughout the incubation period. Values are normalized to the Bmax of the control samples for each graph. Data points are the mean (±S.E.) of three
independent binding assays using mitochondrial vesicles and five independent binding assays using cardiac SR microsomes. Lines linking data points have no
theoretical meaning.
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most extreme example, that of the Ca2+-dependent inactivation
of binding at pCa 3 in control conditions, binding is almost null
in RyR1 [32,35] and mRyR (Fig. 1C), but robust in cardiac SR
(Fig. 1D). Thus, mRyR behaved like RyR1 in [3H]ryanodine
binding assays, and not as RyR2 as expected if the
mitochondrial samples used in this study were contaminated
by SR proteins. Our results therefore suggest that the mRyR
isolated from mitochondrial membrane vesicles indeed origi-
nates from a separate pool of RyRs.
3.2. Diversity of ion channels in mitochondrial vesicles
In an attempt to characterize the single channel kinetics of the
mRyR, we reconstituted rat IMM or CS vesicles into planar lipid
bilayers as described [32,33]. The conditions used for theseTable 1
Succinate dehydrogenase (SDH) activity is enriched in the IMM fraction
Compartment SDH activity [mU/mg]±SE
Mitochondria 704.837±68.351
Cytosol 10.138±2.364
OMM 1.355±1.062
CS 337.629±55.646
IMM 2598.589±318.596experiments (see Materials and methods) theoretically should
favor recording of large currents through RyRs while silencing
other unrelated channels. In some experiments, 20 mMKCl was
added to the recording solution, as Cl− ions have proved
effective in enhancing RyR activity [34]. A variety of substates
from individual or multiple types of channels were generally
seen, obstructing the identification of unitary conductances (Fig.
2A, B), but even then, there were instances in which a potential
mRyR was conspicuous within the recording. In Fig. 2A for
example, the expanded section of the recording contained single
channel fluctuations that had gating kinetics and unitary
conductance remarkably similar to SR-RyR. The full, unitary
Cs+ conductance of this 500 ms segment was 661 pS; in
addition, the channel was unresponsive to 2 μM CsA, a
concentration that effectively blocks the mitochondrial perme-
ability transition pore (PTP) [36]. These brief occurrences of
RyR-like channel gating were promising and demonstrated the
possibility that, in the absence of other unrelated currents, a
channel from the IMM with similar conductance as the SR-RyR
may fuse into the planar lipid bilayer.
Given the heterogeneity of channels in the mitochondrial
membranes [37,38], other channels could be able to conduct
Cs+ as well and may have been enhanced by the presence of
KCl in the recording medium. Fig. 2B shows traces of steady-
state activity from several channels or multiple substates of an
Fig. 3. Silver staining analysis of a RyR from purified IMM and CS subfractions.
Following CHAPS solubilization and sucrose gradient centrifugation, several
membrane fractions were collected, samples (40 μg) were run on an SDS-PAGE
gel, and stained with silver salts to test the validity of the purification method.
The arrow indicates the position of a 200-kDa molecular weight myosin marker
molecule. The silver salts stained a protein band of approximately 500 kDa.
MW, kaleidoscope prestained standard markers (Bio-Rad); Frog somes, frog
skeletal SR-enriched microsomes 40 k pellet; Frog F1, purified frog skeletal
fraction 1 (20% sucrose); Pig F1, purified pig cardiac fraction 1 (20% sucrose);
IMM F1, purified IMM fraction 1 (20% sucrose); CS F3, purified CS fraction 3.
Fig. 2. Detection of mitochondrial channels in planar lipid bilayers. (A) Single mitochondrial channel recorded from IMM vesicle reconstituted into a planar lipid
bilayer. The enlarged portion of the trace represents a potential mRyR. Channel openings are represented as downward deflections of the base-line current. Solutions in
both chambers bathing the planar bilayer were (in mM) 300 Cs+ methanesulfonate, 20 KCl, and 20 MOPS (pH 7.2) along with nominal levels of Ca2+ (∼3–5 μM).
After channel fusion, 2 μMCsAwas added to the cis side in each experiment. With a holding potential of −30 to −40 mV, Cs+ current flows from the trans (luminal) to
cis (cytosolic) side. All records were low pass filtered at 1.5 kHz using an 8-pole Bessel filter and digitized at 4 kHz. (B) Representative single channel traces of a
variety of ion channels/channel substates from IMM vesicles under the same conditions as described above. Traces b, c, and d have the same current/time scale as
trace e. c: closed state of the channels.
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potential of −30 to −40 mV in the presence of nominal levels of
Ca2+ (∼3–5 μM). Interestingly, several mitochondrial currents
recorded such as traces 2B-b, c, and e, had extremely fast gating
and transitioned between a variety of conductance states. These
channels/channel substates most likely correspond to the PTP
and/or VDAC, or translocases of the inner membrane, when
compared with published electrophysiological characterizations
of these channels (for review see [36]). Trace 2B-c, for example,
was inhibited by the addition of 2 μM CsA as shown in Fig. 2
(see the last 1.2 s) suggesting that this channel is indeed the PTP.
3.3. Purification of mitochondrial subfractions by sucrose
gradient centrifugation
Single channel recordings such as those depicted in Fig. 2
substantiated the necessity for additional purification of the
mitochondrial subfractions in order to isolate the mRyR. We
used sucrose-gradient sedimentation of solubilized IMM or CS
vesicles to purify the mRyR, as originally described for SR-RyR
[5,29]. The sedimentation coefficient for the RyR is 30 S [39],
thus the RyR localizes in the heavier sucrose fractions with this
technique. Frog skeletal and pig cardiac SR-enriched micro-
somes were subjected to the same treatment as the mitochon-
drial subfractions and were used as positive controls (Fig. 3,Frog-F1 and Pig-F1). The occurrence of a high molecular
weight band (∼500 kDa) in the purified IMM or CS fractions
with migration similar to SR-RyR monomers was confirmed by
silver staining (Fig. 3). Fig. 3 verifies that the mRyR localized
within the heavier, 20% sucrose fractions (IMM-F1, CS-F3).
The detection of the mRyR within the heavier sucrose fractions
confirmed that the mRyR may be isolated in an analogous
1789B.A. Altschafl et al. / Biochimica et Biophysica Acta 1768 (2007) 1784–1795manner as the SR-RyR; we thus obtained a more purified
preparation to use in lipid bilayer experiments.
3.4. Single channel kinetics of the mRyR
In order to facilitate fusion of mRyR into planar lipid
bilayers, we reconstituted the solubilized IMM and CS proteins
into proteoliposomes using the procedure described by Lee et al.
[31]. We used single channel conductance as the first of a series
of biophysical and pharmacological criteria to designate
mitochondrial channels as mRyRs [40,41]. Accordingly,
profiles of single channels likely corresponding to mRyRs
solely based on their unitary channel conductances were
recorded (n=21). Fig. 4A shows six representative channels
reconstituted from the IMM or CS purified fractions that display
conductance values similar to Cs+-conducting SR-RyRs. Traces
a, b, and c represent channels fused from purified IMM
proteoliposomes, while traces d, e, and f are channels fused
from purified CS proteoliposomes. All channels depicted in Fig.
4A were recorded at −20 to −50 mV, thus downward de-
flections of the baseline current correspond to channel open-
ings. In all traces there are discrete, fully-resolved openings that
are characteristic of classical RyRs. Some of the openings are
longer lasting (traces c and d) and some are fast-flickeringFig. 4. A kinetic profile of the mitochondrial ryanodine receptor. (A) RyRs from purif
into planar lipid bilayers. Traces a, b, and c represent single channel recordings of th
recordings from purified CS proteoliposomes. Channels are activated by steady app
deflections of the base-line current represent the open state of the channel. The
methanesulfonate, 20 KCl and 20 MOPS (pH 7.2). All recordings were made in the
addition of 2 μMCsA. (B) Single channel current–voltage relationship for trace a fro
state of the RyRs.(trace f). In some of the recordings (traces a and e), the channels
enter into periods of half-conductance states that are reminiscent
of the intrinsic subconductance states present in SR-RyRs [39].
Thus, most kinetic states previously reported for SR-RyRs [7]
are represented in our mRyR recordings. Fig. 4B displays a
representative single channel current–voltage relationship of
these mitochondrial channels (trace 4A-a). In the range of −30
to +20 mV, the slope conductance was 616±41 pS when
measured in symmetrical 300 mM cesium methanesulfonate
solution. Overall, the unitary conductance for the purified IMM
or CS channels presented in Fig. 4 fluctuated between 550 and
790 pS, values which are close to those expected for SR-RyR
under these recording conditions [42]. The slight but significant
deviation of these values from the average Cs+-conducting SR-
RyR is most likely due to modifications of the recording
solution (See Discussion).
3.5. Calcium activation of the mRyR
Next, we investigated the effects of some classical RyR
modulators on mitochondrial channels that had conductance
measurements appropriate for RyRs as described above. The
RyRs in the SR of both cardiac and skeletal muscle are activated
by nanomolar to micromolar concentrations of Ca2+ [34]. Weied IMM and CS subfractions were reconstituted into proteoliposomes and fused
e mRyR from purified IMM proteoliposomes, while traces d, e, and f are mRyR
lied negative recording potentials of between −20 to −50 mV, thus downward
recording solution for all of the experiments contained (in mM) 300 Cs+
presence of nominal levels of Ca2+ (∼3–5 μM) and were unresponsive to the
m panel Awith a linear slope conductance measurement of 616±41 pS. c: closed
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mRyR. For a side-by-side comparison of solubilized and
partially purified channels, we used the RyRs from frog skeletal
muscle that were separately subjected to the sucrose sedimenta-
tion technique described in Fig. 3. Frog skeletal muscle is highly
enriched with RyRs, and although it contains two RyR isoforms
(alpha-RyR and beta-RyR, [43]) they are kinetically indis-
tinguishable from mammalian RyRs in single channel record-
ings, thus we chose this high-density RyR preparation as our
control. Fig. 5 shows that the frog skeletal SR-RyR and the rat
cardiac mRyR response to Ca2+ was strikingly similar. The top
single channel recordings of the SR-RyR andmRyR (Fig. 5A, B,
respectively) represent control conditions in the absence of
modulators except for the presence of nominal levels of Ca2+ in
the recording solution (∼3–5 μM). Under these control
conditions, the conductance for the SR-RyR and the mRyR
was 555 and 626 pS, respectively. Ca2+ (50 μM added to the cis
chamber) activated the SR-RyR and mRyR by increasing both
bursting frequency and mean open time (Fig. 5C, D). Following
addition of Ca2+, the open probability (Po) increased from 0.065Fig. 5. Comparison of the Ca2+ activating effect on SR-RyR and the mRyR. Sing
phosphotidlyethanolamine and phosphatidylserine (1:1). Single channel data were
methanesulfonate after dissipation of the 50 mM Cs+ methanesulfonate gradient in th
the channel, which contained the voltage command electrode. (A) Representative rec
RyR) and (B) the IMM (mRyR) from rat cardiac preparations in the absence of added
RyR from frog skeletal muscle and (D) the rat cardiac IMM (n=5). (E and F) Current
rat cardiac IMM, respectively, before and after the addition of Ca2+. (G and H) Mean
(H) before (black bars, Control) and after (gray bars) the addition of Ca2+. The light gr
plots before and after the addition of Ca2+, respectively. The number of observations
Ca2+), 335 (mRyR Control), and 2059 (mRyR with Ca2+). c: closed state of the SR-Ry
of Ca2+ for the SR-RyR and the mRyR.to 0.36 and from 0.034 to 0.40 for the SR-RyR and the mRyR
channel, respectively. Amore quantitative description of the effect
of Ca2+ on channel activity can be calculated from the open time
histograms (Fig. 5G, H). Under control conditions, open events of
the SR-RyR could be fit best by a double exponential with
τopen1=0.979±0.047 ms (61%) and τopen2=5.453±0.029 ms
(39%), while mRyR openings were best fit with a single
exponential, τopen1=0.662±0.049 ms. In the presence of 50 μM
Ca2+ the open time histograms were biexponential for both SR-
RyR [τopen1=0.746±0.056 ms (55%) and τopen2=4.621±
0.016 ms (45%)] and the mRyR [τopen1=0.597±0.153 ms
(53%) and τopen2=3.593±0.034 ms (47%)]. These data (Fig. 5G
and H) and the current amplitude histograms for the SR-RyR and
the mRyR (Fig. 5E and F, respectively) delineate the agonistic
effect of Ca2+ on both groups of channels.
3.6. Ryanodine activation of the mRyR
In the presence of sub- to low micromolar concentrations of
ryanodine, SR-RyRs lock into a distinct conformational statele channel recordings of purified RyRs in planar lipid bilayers composed of
collected at steady voltages (−25 to −30 mV) in symmetrical 300 mM Cs+
e trans chamber. Proteoliposomes of purified RyRs were added to the cis side of
ordings of the baseline activity of a RyR channel from frog skeletal muscle (SR-
Ca2+. (C) Ca2+ increases the open probability (Po) of channel activity of the SR-
amplitude histograms of RyR channel activity from frog skeletal muscle and the
open time histograms of the frog skeletal SR-RyR (G) and the rat cardiac mRyR
ay and black solid lines represent the exponential decay fittings of the dwell time
collected during a 30 s period were 695 (SR-RyR Control), 1454 (SR-RyR with
R and mRyR. * indicates the number of open events before and after the addition
Fig. 6. Ryanodine induces subconducting states in mRyR channels. Single channel recordings of purified mRyRs recorded using the same conditions as described in
Materials and methods and in Fig. 5 legend. (A) a: representative recording of the baseline activity of a mRyR from the IMM in the absence of ryanodine. b and c: Po
and current amplitude histograms, respectively, of RyR channel activity before the addition of modulators. (B) a: representative recording of mRyR single channel
activity after the addition of 10 μM ryanodine to the cis chamber (n=3). b and c: Po and current amplitude histograms, respectively, demonstrating the initial activating
effect of ryanodine because of prolonged subconducting activity. c: closed state of the mRyR.
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senting ∼50% of full conductance [3]. We therefore tested the
effect of ryanodine on mitochondrial channels. Fig. 6 shows an
IMM channel reconstituted in a lipid bilayer in the absence
(control, Fig. 6A-a), and the presence (Fig. 6B-a) of 10 μM
ryanodine added to the cis chamber. Under control conditions
(Fig. 6A) the channel displayed quick, intermittent openings
that resulted in overall low Po of 0.023 for the duration of the
recording. The diary of activity for the first 20 s of channel
recording (Fig. 6A-b) emphasizes the quiescent nature of this
channel in the absence of external modulators. By contrast,
addition of 10 μM ryanodine to the channel (Fig. 6B) drama-
tically altered its activity by inducing the appearance of a half-
conducting state that lasted for several seconds as depicted in
the diary of openings (Fig. 6B-b) and the current amplitude
histogram (Fig. 6B-c). Even then, the channel also showed an
uncharacteristic response to ryanodine by alternating between
periods of sub- and full-conducting openings for the first ten s,
followed by complete inhibition throughout the remainder of
the recording (Fig. 6B-b). As a result of this bimodal effect, the
Po initially increased to 0.97, presumably while ryanodine
exerted its activating effect, and then fell to zero as ryanodine
exerted a blocking effect. The normalized Po for the first 20 s
was therefore 0.13 and zero thereafter. Interestingly, we found
no mitochondrial channels that irreversibly locked intosubconducting states by ryanodine. There were channels com-
pletely inhibited by 10 μM ryanodine (n=2), while other
channels displayed alternating periods of sub- and full-
conducting states (n=3) in response to ryanodine.
3.7. Imperatoxin A induces mRyR subconductance
Unlike its differential effects on the Ca2+ dependence of [3H]
ryanodine binding, IpTxa affects the single channel kinetics of
all RyR isoforms (RyR1, RyR2 and RyR3) in a similar manner
[35,44]. Like ryanodine, IpTxa at nanomolar concentrations
induces the appearance of long-lasting subconductance states in
both SR-RyR isoforms, RyR1 and RyR2. At negative recording
potentials (such as those used for these experiments), the
substate conductance represents approximately 43% of the full
conductance openings [35]. Unlike ryanodine, however, the
reversible binding of IpTxa allows the channel to fluctuate
between sub- and full-conducting states. Fig. 7 shows that,
remarkably, IpTxa exhibited its classical activating effect on
a reconstituted mRyR channel purified from mitochondrial
subfractions.
The mRyR depicted in Fig. 7A was recorded under control
conditions (in a nominally-free Ca2+ solution without additional
modulators) and had gating kinetics characteristic of SR-RyRs,
i.e., numerous fast openings alternating with few long-lasting
1792 B.A. Altschafl et al. / Biochimica et Biophysica Acta 1768 (2007) 1784–1795openings, both giving rise to sporadic bursts of channel activity.
The overall activity and conductance of the channel are
summarized in the current amplitude histogram (Fig. 7A, right
panel). Conversely, the same channel after addition of 500 nMIpTxa (Fig. 7B, left panel) and the resulting amplitude
histogram (Fig. 7B, right panel) displayed the signature effect
of IpTxa on the mRyR. The toxin induced long-lasting
subconducting states interspersed between periods of full-
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ductance approximated 40% of the full conductance openings.
The amplitude histogram of mRyR channel activity (Fig. 7B,
right panel) emphasizes that modulation by IpTxa increased the
Po of the mRyR by increasing the frequency of channel
openings and decreasing the duration of the closed events.
Indeed, mRyR Po augmented from 0.13 in control to 0.86 in the
presence of IpTxa (Fig. 7A and B, respectively). In Fig. 7C we
compared the gating of the presumed mRyR with that of frog
SR-RyR recorded under identical experimental conditions. As
shown in the compressed and expanded traces, the activity of
both channels oscillated between periods of long-lasting
subconductance states, representing occupation of the channel
by IpTxa [35], and normal full conductance openings,
representing gating of IpTxa-free channels. Notice the remark-
able resemblance in the gating characteristics of both channels.
4. Discussion
The availability of techniques that segregate mitochondrial
subfractions from SR and other membrane particulates [14,15]
has made it possible to identify a channel protein with physical
characteristics similar to those of SR-RyRs in an unusual
location, the mitochondria. The differential effects of IpTxa on
the Ca2+ dependence of [3H]ryanodine binding (Fig. 1C, D)
reinforce the notion that mRyR has exquisite functional
differences with the SR-RyR from cardiac tissue. Likewise,
Western blots of the mitochondrial subfractions recognize a
high molecular weight (∼500 kDa) band within the IMM that
cross-reacts with RyR1 (skeletal isoform) but not RyR2 (cardiac
isoform) specific antibodies, again strengthening the assertion
that this protein is a unique mitochondrial component and not an
SR contaminant (which would otherwise yield a strong RyR2
signal) [15]. [3H]Ryanodine, a specific ligand of the SR-RyR,
binds to mitochondrial vesicles with high affinity, and in the
presence of ryanodine, Ca2+ uptake into isolated heart
mitochondria is substantially suppressed [14]. Thus, a protein
similar to SR-RyR appears to be an important functional Ca2+
transporter within the IMM.
The present study demonstrates that the mitochondria
contain a functional RyR within the IMM that shares several
pharmacological and electrophysiological characteristics with
the SR-RyR at the single channel level. We reasoned that the
presently described mRyR is of mitochondrial origin and free
from RyR2 contamination on the following grounds: (1) IMM
and CS subfractions were free from detectable amounts of
SERCA and calsequestrin protein (Fig. 1A and B, respectively),
indicative for SR; (2) some of the channels fused into lipid
bilayers were blocked by CsA, indicating that these vesicles
contained the mitochondrial PTP; (3) ryanodine exertedFig. 7. Imperatoxin A achieves its classical RyR effect by inducing periodic, prolonged
recorded using the same conditions as described inMaterials andmethods. (A) Represe
without the presence of RyR modulators. The right panel represents a current amplitu
depicted in panel A recorded after the addition of 500 nM IpTxa to the cis chamber (n
after IpTxa took effect. (C) The effects of IpTxa activity on a frog skeletal SR-RyR vs. t
presence of IpTxa. The enlarged trace represents a 2-s subsection of the channel record
subfractions in the presence of IpTxa. The enlarged trace represents a 2-s subsectiondistinctive effects on mRyR that differ from those exerted by
the alkaloid on RyR2 (Fig. 6), suggesting that mRyR represents
a RyR isoform that retains the bulk of RyR properties but
maintains unique characteristics, akin to the different Ca2+-
dependence of channel activity seen with RyR1 and RyR2
[34,45]; and (4) the Ca2+ dependence of [3H]ryanodine binding
in the presence and absence of IpTxa to IMM vesicles was
analogous to that expected for RyR1 (Fig. 1C, D), consistent
with Western blot data [15], and different from that of RyR2, as
would be expected if cardiac SR vesicles contaminated our
IMM preparations.
The IMM contains a variety of proteins, which exhibit
channel activity in bilayer membranes, including the Ca2+
uniporter [46], the ANT [47–49], and proteins of the
mitochondrial protein transport system [50]. Several studies
support the hypothesis that the PTP is a protein complex
containing components of the IMM, such as the ANT, and the
OMM, such as VDAC [51,52]. Given the high sensitivity of our
electrophysiological assay, it was not surprising that we
reconstituted a multiplicity of ion channels from the IMM or
CS subfractions (Fig. 2). Some of the traces depicted in Fig. 2
were from channels of unknown molecular identity, so it is
likely that we recorded IMM transport proteins that have not yet
been fully characterized in lipid bilayer experiments. Unfortu-
nately, our single channel lipid bilayer assay does not allow us
to determine the precise location of the mRyR within the
distinct mitochondrial substructures. However, VDAC, a
marker protein for the OMM, was below detection levels in
Western blot characterization of IMM vesicles, which most
likely excludes the localization of mRyR in OMM. Importantly,
we had the most success fusing mRyR channels from the IMM
preparations (the mitochondrial subfraction used for the
majority of the experiments described in this study). Therefore,
if we make the reasonable assumption that the likelihood of
detecting a protein in a given vesicular preparation is directly
proportional to the relative abundance of the protein in the same
preparation, then the higher frequency of mRyR detection in
IMM vesicles favors the notion that IMM is the preferred
location of this channel, in agreement with supporting data
obtained by electron microscopy and Western blot analysis with
RyR antibodies [14,15].
Traditionally, the enormous mass (∼2 million Da/channel
tetramer) and sedimentation coefficient (30 S) of the SR-RyR
have been exploited for separation of this channel from other SR
proteins [29,39]. Purification by sucrose gradient centrifugation
also proved successful to separate the mRyR from other
mitochondrial channels (Fig. 3). This provided further evidence
that the mRyR is a channel complex that can be purified with the
same methods used for the SR-RyR. Nevertheless, in spite of
mRyR enrichment, we continued to detect “contaminating”substates of mRyR channel activity. Single channel recordings of purified mRyRs
ntative single channel profile of mRyR recorded in a nominally-free Ca2+ solution
de histogram for 30 s of the trace represented on the left. (B) The same channel
=5). The right panel represents a current amplitude histogram for 30 s of the trace
he rat cardiac mRyR. Top: a 1-min recording of a RyR from frog skeletal SR in the
ing. Bottom: a 1-min recording of a RyR from purified rat cardiac mitochondrial
of the mRyR channel recording. c: closed state of the SR-RyR and mRyR.
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correspond to the mRyR. The predominant types of unrelated
channels were blocked by CsA, suggesting that the PTP may
have co-segregated with the mRyR in our sucrose sedimentation
procedure. It has been hypothesized that the PTP is a multi-
protein complex, which may consist of VDAC, the ANT,
hexokinases [51], and the benzodiazepine receptor [53] all
having a total molecular weight of ∼600 kDa. Given the large
molecular weight of the PTP multi-protein complex and that of
the mRyR, it is probable that both of these protein complexes
could colocalize within the heavier sucrose fractions.
In order to characterize the mRyR at the single channel level,
we established a set of criteria to designate certain channels as
mRyR candidates. The first index of activity to categorize a
mitochondrial channel as potential mRyR was single channel
conductance. Smith et al. [42] found that RyR1 conducts Cs+ at
higher rate than other monovalent cations. For example, in
recording solution containing 50 mM cis and 250 mM trans
[Cs+], the unitary conductance of RyR1 is ∼500 pS [42]. For
the present study, we used 50 mM cis and 300 mM trans [Cs+]
(and then dissipated the gradient following channel fusion so
that both sides of the mRyR contained 300 mM Cs+), predicting
mRyR single channel unitary conductances of 500–600 pS.
Nevertheless, the addition of KCl to the recording solution may
have caused the mRyR conductance to deviate from those
values expected for a Cs+-conducting RyR1. When millimolar
concentrations of KCl were added to the recording solution to
favor channel activity, we expected an increase of RyR
conductance to above 600 pS [42], which we observed in the
single channel mRyR experiments recorded under these
conditions (Fig. 4A, traces a–e). This was possibly the single
most significant factor in the unitary conductance variation we
observed (Fig. 4), followed perhaps by Cs+ leak from cis to
trans chambers during bilayer re-painting and the intrinsic noise
of the high-frequency recording bandwidth (1.5 kHz).
The second criterion to designate channel activity as that
corresponding to mRyR was the lack of response to CsA
(∼2 μM), excluding the possibility that the channel recordings
represented substates of the PTP, which can rapidly flicker from
its fully closed state to a substate of 600–700 pS [37]. Finally,
we expected the candidate channels to be sensitive to Ca2+,
ryanodine, and IpTxa (Figs. 5–7) because, although with small
variations, these modulators produce signature effects on all
RyR isoforms. The profile of the single channel recordings and
the unitary Cs+ conductance measurements of the channels
depicted in Fig. 4A, as well as their lack of modulation by CsA,
confirmed that these channels are indeed representative of the
mRyR. Likewise, as seen in Figs. 5–7, the mRyR displayed the
elemental attributes that are present in single channel lipid
bilayer recordings of a SR-RyR and responded similarly to
classical modulators of SR-RyR activity.
Using these criteria, we have determined some of the most
salient pharmaco-kinetic characteristics of the mRyR. The
mRyR described in this study displays gating properties
reminiscent of those seen in the classical SR-RyR, including
an analogous conductance for monovalent cations and Ca2+
sensitivity. The mRyR conforms to a ryanodine-altered substatein the presence of the ligand, and IpTxa binds reversibly to the
mRyR allowing for the oscillation of channel activity from
subconducting to full-conducting states. Future experiments
should determine whether the typical SR-RyR accessory
proteins are associated with this intriguing mRyR and if their
modulatory effects are similar in a novel environment. Equally
important, the present functional assays should provide a
practical platform to test the role of the mRyR as a modulator of
Ca2+ fluxes in mitochondria and as a transducer for excitation–
metabolism coupling in cardiac cells.
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